Search Results
You are looking at 1 - 3 of 3 items for
- Author: J D Zajac x
- Refine by access: All content x
Search for other papers by A J Notini in
Google Scholar
PubMed
Search for other papers by R A Davey in
Google Scholar
PubMed
Search for other papers by J F McManus in
Google Scholar
PubMed
Search for other papers by K L Bate in
Google Scholar
PubMed
Search for other papers by J D Zajac in
Google Scholar
PubMed
Androgens mediate their effects in target cells via the androgen receptor (AR), which acts predominantly as a ligand-dependent transcription factor. In addition, androgens induce rapid activation of second messenger signal transduction cascades, and this is thought to occur via non-genomic mechanisms. We have used the Cre/loxP system to generate an AR knockout (ARKO) mouse targeting exon 3, which encodes the second zinc finger of the DNA-binding domain. To generate universal ARKO mice, floxed AR mice were mated with CMV-Cre mice, which express Cre recombinase ubiquitously. Deletion of the floxed allele in our mice does not disrupt the reading frame, and has been designed so that the mutant AR can bind ligand but not target genes. ARKO males displayed a complete androgen insensitivity phenotype, with female external genitalia and a reduction in body weight compared with wild-type males (P < 0.001). Testes of ARKO males were smaller than control males (P < 0.0001) and were located intra-abdominally. We have demonstrated that genotypically XY mice lacking the second zinc finger of the AR have a female phenotype, and we conclude that the genomic actions of the AR (mediated by DNA binding) are indispensable for normal male sexual differentiation.
Search for other papers by D M Thomas in
Google Scholar
PubMed
Search for other papers by S D Rogers in
Google Scholar
PubMed
Search for other papers by M W Sleeman in
Google Scholar
PubMed
Search for other papers by G M Pasquini in
Google Scholar
PubMed
Search for other papers by F R Bringhurst in
Google Scholar
PubMed
Search for other papers by K W Ng in
Google Scholar
PubMed
Search for other papers by J D Zajac in
Google Scholar
PubMed
Search for other papers by J D Best in
Google Scholar
PubMed
ABSTRACT
This study characterizes the actions of insulin and parathyroid hormone (PTH) on the glucose transport system in the rat osteogenic sarcoma cell line UMR 106–01, which expresses a number of features of the osteoblast phenotype. Using [1,2-3H]2-deoxyglucose (2-DOG) as a label, UMR 106–01 cells were shown to possess a glucose transport system which was enhanced by insulin. In contrast, PTH influenced glucose transport in a biphasic manner with a stimulatory effect at 1 h and a more potent inhibitory effect at 16 h on basal and insulin-stimulated 2-DOG transport. To explore the mechanism of PTH action, a direct agonist of cAMP-dependent protein kinase (PKA) was tested. 8-Bromo-cAMP had no acute stimulatory effect but inhibited basal and insulin-stimulated 2-DOG transport at 16 h. This result suggested that the prolonged, but not the acute, effect of PTH was mediated by the generation of cAMP. Further studies with the cell line UMR 4–7, a UMR 106–01 clone stably transfected with an inducible mutant inactive regulatory subunit of PKA, confirmed that the inhibitory but not the stimulatory effect of PTH was mediated by the PKA pathway. Northern blot data indicated that the prolonged inhibitory effects of PTH and 8-bromo-cAMP on glucose transport were likely to be mediated in part by reduction in the levels of GLUT1 (HepG2/brain glucose transporter) mRNA.
Search for other papers by SJ Kaczmarczyk in
Google Scholar
PubMed
Search for other papers by S Andrikopoulos in
Google Scholar
PubMed
Search for other papers by J Favaloro in
Google Scholar
PubMed
Search for other papers by AA Domenighetti in
Google Scholar
PubMed
Search for other papers by A Dunn in
Google Scholar
PubMed
Search for other papers by M Ernst in
Google Scholar
PubMed
Search for other papers by D Grail in
Google Scholar
PubMed
Search for other papers by M Fodero-Tavoletti in
Google Scholar
PubMed
Search for other papers by CE Huggins in
Google Scholar
PubMed
Search for other papers by LM Delbridge in
Google Scholar
PubMed
Search for other papers by JD Zajac in
Google Scholar
PubMed
Search for other papers by J Proietto in
Google Scholar
PubMed
The aim of this study was to investigate the metabolic and structural consequences of a decrease in glucose transporter-4 (GLUT4) levels on the heart. The CreLoxP system was utilised to delete GLUT4 in muscle tIssue including heart. The presence of the PGK-neoR cassette in the GLUT4-Lox mice resulted in reduced expression in all tIssues to levels 15-30% of wild-type control mice. In mice expressing Cre recombinase, there was a further reduction of GLUT4 in cardiac tIssue to almost undetectable levels. Cardiac glucose uptake was measured basally and during a euglycaemic/hyperinsulinaemic clamp using 2-deoxy-[1-(14)C]glucose. Insulin-stimulated glucose uptake was normal in hearts expressing 15% of normal GLUT4 levels but markedly reduced in mice with more profound reduction in GLUT4. Cardiac enlargement occurred only when GLUT4 levels were less than 5% of normal values. In heart there is a threshold level of GLUT4 above which insulin-stimulated glucose uptake is maintained. As little as 5% of normal GLUT4 levels expressed in heart is sufficient to prevent the development of cardiac hypertrophy.
